Literature DB >> 23100365

Theiler's murine encephalomyelitis virus contrasts with encephalomyocarditis and foot-and-mouth disease viruses in its functional utilization of the StopGo non-standard translation mechanism.

G Loughran1, J E Libbey2, S Uddowla3, M F Scallan4, M D Ryan5, R S Fujinami2, E Rieder3, J F Atkins6,4,1.   

Abstract

The picornaviruses' genome consists of a positive-sense ssRNA. Like many picornaviruses, cardioviruses synthesize two distinct polyprotein precursors from adjacent but non-overlapping genome segments. Both the [L-1ABCD-2A] and the [2BC-3ABCD] polyproteins are proteolytically processed to yield mature capsid and non-structural proteins, respectively. An unusual translational event, known as 'StopGo' or 'Stop-Carry on', is responsible for the release of the [L-1ABCD-2A] polyprotein from the ribosome and synthesis of the N-terminal amino acid of the [2BC-3ABCD] polyprotein. A common feature of these viruses is the presence of a highly conserved signature sequence for StopGo: -D(V/I)ExNPG(↓)P-, where -D(V/I)ExNPG are the last 7 aa of 2A, and the last P- is the first amino acid of 2B. Here, we report that, in contrast to encephalomyocarditis virus and foot-and-mouth disease virus, a functional StopGo does not appear to be essential for Theiler's murine encephalomyelitis virus viability when tested in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100365      PMCID: PMC3709618          DOI: 10.1099/vir.0.047571-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

1.  Proteolysis at the 2A/2B junction in Theiler's murine encephalomyelitis virus.

Authors:  S Batson; K Rundell
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

2.  A case for "StopGo": reprogramming translation to augment codon meaning of GGN by promoting unconventional termination (Stop) after addition of glycine and then allowing continued translation (Go).

Authors:  John F Atkins; Norma M Wills; Gary Loughran; Chih-Yu Wu; Krishna Parsawar; Martin D Ryan; Chung-Hsiung Wang; Chad C Nelson
Journal:  RNA       Date:  2007-04-24       Impact factor: 4.942

3.  The cleavage activities of aphthovirus and cardiovirus 2A proteins.

Authors:  M L Donnelly; D Gani; M Flint; S Monaghan; M D Ryan
Journal:  J Gen Virol       Date:  1997-01       Impact factor: 3.891

4.  A detailed kinetic analysis of the in vitro synthesis and processing of encephalomyocarditis virus products.

Authors:  R J Jackson
Journal:  Virology       Date:  1986-02       Impact factor: 3.616

5.  A comparison of the neurotropism of Theiler's virus and poliovirus in CBA mice.

Authors:  D Villarreal; C R Young; R Storts; J W Ting; C J R Welsh
Journal:  Microb Pathog       Date:  2006-08-28       Impact factor: 3.738

6.  Attenuation of Mengo virus through genetic engineering of the 5' noncoding poly(C) tract.

Authors:  G M Duke; J E Osorio; A C Palmenberg
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

7.  Ribosomal frameshifting into an overlapping gene in the 2B-encoding region of the cardiovirus genome.

Authors:  Gary Loughran; Andrew E Firth; John F Atkins
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

8.  Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice.

Authors:  E Rieder; T Bunch; F Brown; P W Mason
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Proteolytic processing of the cardioviral P2 region: primary 2A/2B cleavage in clone-derived precursors.

Authors:  A C Palmenberg; G D Parks; D J Hall; R H Ingraham; T W Seng; P V Pallai
Journal:  Virology       Date:  1992-10       Impact factor: 3.616

10.  Occurrence, function and evolutionary origins of '2A-like' sequences in virus genomes.

Authors:  Garry A Luke; Pablo de Felipe; Alexander Lukashev; Susanna E Kallioinen; Elizabeth A Bruno; Martin D Ryan
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891

View more
  7 in total

1.  Modifications to the Foot-and-Mouth Disease Virus 2A Peptide: Influence on Polyprotein Processing and Virus Replication.

Authors:  Jonas Kjær; Graham J Belsham
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 2.  From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.

Authors:  John F Atkins; Kate M O'Connor; Pramod R Bhatt; Gary Loughran
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.048

3.  Characterization of Ribosomal Frameshifting in Theiler's Murine Encephalomyelitis Virus.

Authors:  Leanne K Finch; Roger Ling; Sawsan Napthine; Allan Olspert; Thomas Michiels; Cécile Lardinois; Susanne Bell; Gary Loughran; Ian Brierley; Andew E Firth
Journal:  J Virol       Date:  2015-08       Impact factor: 5.103

4.  Selection of functional 2A sequences within foot-and-mouth disease virus; requirements for the NPGP motif with a distinct codon bias.

Authors:  Jonas Kjær; Graham J Belsham
Journal:  RNA       Date:  2017-10-17       Impact factor: 4.942

5.  An analysis by metabolic labelling of the encephalomyocarditis virus ribosomal frameshifting efficiency and stimulators.

Authors:  Roger Ling; Andrew E Firth
Journal:  J Gen Virol       Date:  2017-08-08       Impact factor: 3.891

6.  Protein-directed ribosomal frameshifting temporally regulates gene expression.

Authors:  Sawsan Napthine; Roger Ling; Leanne K Finch; Joshua D Jones; Susanne Bell; Ian Brierley; Andrew E Firth
Journal:  Nat Commun       Date:  2017-06-08       Impact factor: 14.919

7.  Investigating molecular mechanisms of 2A-stimulated ribosomal pausing and frameshifting in Theilovirus.

Authors:  Chris H Hill; Georgia M Cook; Sawsan Napthine; Anuja Kibe; Katherine Brown; Neva Caliskan; Andrew E Firth; Stephen C Graham; Ian Brierley
Journal:  Nucleic Acids Res       Date:  2021-11-18       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.